Multiple myeloma: practice patterns across Europe-Reference-Cited by-同舟云学术

Multiple myeloma: practice patterns across Europe

Published:2016-06-13 Issue:1 Volume:175 Page:66-76
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Raab Marc S.¹^ORCID,Cavo Michele²,Delforge Michel³,Driessen Christoph⁴,Fink Leah⁵,Flinois Alain⁵,Gonzalez‐McQuire Sebastian⁶,Safaei Reza⁶,Karlin Lionel⁷,Mateos Maria‐Victoria⁸,Schoen Paul⁶,Yong Kwee⁹

Affiliation:

1. Department of Internal Medicine University of Heidelberg Heidelberg Germany

2. “Seràgnoli” Institute of Haematology and Medical Oncology Bologna University School of Medicine Bologna Italy

3. Department of Haematology UZ Leuven Leuven Belgium

4. Department of Oncology and Haematology Kantonsspital St Gallen St Gallen Switzerland

5. Kantar Health Montrouge France

6. Amgen (Europe) GmbH Zug Switzerland

7. Centre Hospitalier Lyon Sud Lyon France

8. Haematology Service University Hospital Salamanca Salamanca Spain

9. Department of Haematology University College London London UK

Funder

Amgen

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.14193

Reference27 articles.

1. Epidemiology of Multiple Myeloma

2. Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction

3. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians

4. Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

5. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma;New England Journal of Medicine;2024-06-03

2. Real-World Registry on the Pharmacotherapy of Multiple Myeloma and Associated Renal and Pulmonary Impairments in the Greater Gulf Region: Protocol for a Retrospective Real-World Data Study;JMIR Research Protocols;2024-04-24

3. Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines;Leukemia Research;2024-04

4. Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden: An analysis using linked Nordic registries;European Journal of Cancer;2024-04

5. Incidence and reasons for discontinuation of first-line therapy in patients with multiple myeloma: results from a historical cohort, Brazil 2009–2020;Annals of Hematology;2024-03-09